• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Compliance and the benefit/risk relationship of antihypertensive treatment.

作者信息

Hasford J

机构信息

Biometrisches Zentrum für Therapiestudien, Munich, Germany.

出版信息

J Cardiovasc Pharmacol. 1992;20 Suppl 6:S30-4.

PMID:1283186
Abstract

Compliance is defined as a patient's behavior in terms of taking prescribed medication, following diets, or executing medically recommended lifestyle changes. Furthermore, compliance measures the extent to which a person's behavior coincides with medical or health advice. The measurement of compliance over time is still a problem. The recently developed medication monitors, however, enable precise documentation of the taking of pills out of the container over long time periods. Long-term compliance with antihypertensive treatments is, referring to the literature, about 50%. The causes of partial compliance are not yet well known. Partial compliance is often accompanied by reduced benefit, e.g., poor blood pressure control. There are even strong arguments that partial compliance increases the risks of treatment, especially with beta-blockers. Thus, the traditional physicians' nonperception of patients' partial compliance is no longer acceptable, as partial compliance has a negative impact on the benefit/risk ratio.

摘要

相似文献

1
Compliance and the benefit/risk relationship of antihypertensive treatment.
J Cardiovasc Pharmacol. 1992;20 Suppl 6:S30-4.
2
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.基层医疗中一日一次与一日两次抗高血压药物治疗的依从性模式:一项使用电子监测的随机临床试验
Can J Cardiol. 1997 Oct;13(10):914-20.
3
Patients' and physicians' assessment of risks associated with hypertension and benefits from treatment.
J Cardiovasc Risk. 1998 Jun;5(3):161-6.
4
Compliance with antihypertensive therapy: raising the bar of expectations.抗高血压治疗的依从性:提高期望标准。
Am J Manag Care. 1998 Jul;4(7):957-66.
5
'Why don't you do as I tell you?' Compliance and antihypertensive regimens.“你为什么不照我说的做?”依从性与抗高血压治疗方案。
Int J Clin Pract. 2002 Apr;56(3):191-6.
6
Factors related to poor control of blood pressure with antihypertensive drug therapy.与抗高血压药物治疗中血压控制不佳相关的因素。
Blood Press. 2003;12(1):49-55.
7
Improved blood pressure control by monitoring compliance with antihypertensive therapy.通过监测抗高血压治疗的依从性改善血压控制。
Int J Clin Pract. 1999 Jan-Feb;53(1):37-8.
8
Control of hypertension in Italy: results of the "Study on Antihypertensive Treatment in General Practice (STAP)". Physicians Taking Part in STAP.意大利高血压的控制:“全科医疗中抗高血压治疗研究(STAP)”的结果。参与STAP研究的医生。
G Ital Cardiol. 1998 Jul;28(7):760-6.
9
Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.药物依从性和持续性是有效抗高血压治疗的基石。
Am J Hypertens. 2006 Nov;19(11):1190-6. doi: 10.1016/j.amjhyper.2006.04.006.
10
Poor blood pressure control: what physicians can do to improve it.血压控制不佳:医生可采取哪些措施来改善
Postgrad Med. 2000 Oct;108(5 Suppl):19-24. doi: 10.3810/pgm.10.2000.suppl8.47.

引用本文的文献

1
Antihypertensive treatment, compliance, and quality of life: Review of a little-understood relation.
J Clin Psychol Med Settings. 1995 Jun;2(2):179-94. doi: 10.1007/BF01988642.
2
Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study.心血管药物的药房用药史与患者访谈之间的一致性:鹿特丹老年人研究
Br J Clin Pharmacol. 1998 Jun;45(6):591-5. doi: 10.1046/j.1365-2125.1998.00716.x.
3
Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers?高血压患者的心脏性猝死。与利尿剂和β受体阻滞剂有关联吗?
Drug Saf. 1997 Apr;16(4):233-41. doi: 10.2165/00002018-199716040-00001.
4
The determinants of hypertension awareness, treatment, and control in an insured population.参保人群中高血压知晓率、治疗率和控制率的决定因素。
Am J Public Health. 1994 Nov;84(11):1768-74. doi: 10.2105/ajph.84.11.1768.